Litcius/Paper detail

Retina as a potential biomarker for the early stage of Alzheimer's disease spectrum

Rong Gao, Huan Luo, Su Yan, Li Ba, Sirui Peng, Bitao Bu, Xufang Sun, Min Zhang

2024Annals of Clinical and Translational Neurology13 citationsDOIOpen Access PDF

Abstract

OBJECTIVE: To characterize the retinal microvasculature and structure in subjective cognitive decline (SCD) and identify the potential biomarker for the early stage of the Alzheimer's disease (AD) spectrum. METHODS: In this study, 35 patients with SCD, 36 with cognitive impairment, and 29 with normal cognition (NC) were enrolled. Optical coherence tomography angiography was employed to assess retinal vascular density, fovea avascular zone area, and retinal thickness. The parameters reflecting retinal perfusion and structure were compared among the three groups. In addition, the association between retinal parameters, cerebral blood flow (CBF), and peripheral blood biomarkers in the SCD stage was analyzed. RESULTS: The superficial vascular complex (SVC) vascular density in the macula and retinal nerve fiber layer thickness in the peripapillary were significantly reduced in individuals with SCD compared to NC. Furthermore, there was a positive correlation between macular ganglion cell complex thickness and CBF in SCD. INTERPRETATION: The retinal microvasculature and structure exhibit alterations in individuals with SCD. Macular ganglion cell complex thickness demonstrates correlations with cerebral perfusion. The retina holds potential as a novel biomarker for early detection of AD.

Topics & Concepts

MedicineRetinalRetinaOphthalmologyBiomarkerNerve fiber layerPerfusionGanglionOptical coherence tomographyOptic nerveGanglion cell layerPathologyCardiologyNeuroscienceAnatomyBiologyBiochemistryRetinal Imaging and AnalysisGlaucoma and retinal disordersRetinal Diseases and Treatments